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Summary
Objective: To investigate the epidemiology and outcome of adult community-
acquired pneumonia (CAP) in tropical Australia.
Methods: A prospective study was performed of all adult patients with CAP admitted
to the Royal Darwin Hospital, a major hospital in tropical northern Australia. A
standard definition of CAP was used and data collected on demographics, risk factors,
history, examination, investigations, treatment and outcome. Locally-developed
treatment guidelines were used.
Results: One hundred and sixty-seven adults were included in the analysis. Aboriginal
people were over-represented, younger and were more likely to have risk factors for
CAP. The most frequent pathogens isolated were Streptococcus pneumoniae and
Burkholderia pseudomallei. ‘Atypical pneumonia’ organisms were uncommon. Treat-
ment guidelines included penicillin for mild pneumonia but emphasised coverage of
Burkholderia pseudomallei in those with risk factors, especially during the monsoon
season. The mortality rate from pneumonia was low with three deaths in 167 cases
(1.8%).
Conclusions: International guidelines for the management of CAP have been based on
populations and organisms from temperate regions and may not necessarily be
applicable to tropical regions. Guidelines based upon local epidemiology must there-* Corresponding author. Tel.: +61 8 89228056; fax: +61 8 89275187.
E-mail address: bart@menzies.edu.au (B.J. Currie).
1201-9712/$30.00 # 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijid.2004.09.008
16 J.H. Elliott et al.
fore be developed. This study illustrates how mortality can be minimised using a
process of determining local CAP etiology, developing treatment guidelines and
auditing patient management.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
Worldwide, lower respiratory tract infections are
the major cause of death1 and they are an increasing
cause of death in industrialised countries.2 Guide-
lines for the management of community-acquired
pneumonia (CAP) have been written for resource-
limited settings3 and for temperate industrialised
countries.1,4—6 In regions such as tropical northern
Australia and tropical ‘middle-income’ countries
there is an unique combination of the availability
of resource-intensive treatments and tropical epi-
demiology. There is a need to develop guidelines for
the management of CAP in these regions based upon
appropriate evidence. The unique epidemiology and
high mortality rate of bacteremic CAP in people
admitted to the Royal Darwin Hospital (RDH) located
in the tropical north of Australia has been previously
documented (Table 1). The hospital’s guidelines
for the treatment of CAP were developed in
response to these data. To investigate CAP treat-
ment outcomes in this setting a prospective study of
all patients admitted over a 12-month period was
performed.Methods
Royal Darwin Hospital (RDH) is the only tertiary
referral hospital for the tropical areas of the North-
ern Territory. It serves a population of around
150,000 (25% Aboriginal) living across an area of
516,945 km2. Royal Darwin Hospital has the only
intensive care unit in the region and so patients
requiring management of severe CAP must be trans-
ferred to RDH. This study did not include patients
admitted to the local private hospital or the two
small regional hospitals unless they were trans-
ferred to RDH.Table 1 Adult community-acquired bacteremic pneumonia
255 cases 84
deaths (33%)
Admissions
Number
of cases
Percentage of
total admissions
Streptococcus pneumoniae 100 39%
Burkholderia pseudomallei 60 24%
Staphylococcus aureus 29 11%
Acinetobacter baumannii 26 10%Patients were eligible for inclusion if they were
admitted to RDH between 1 March 1999 and 29
February 2000, aged 13 years or older, diagnosed
with pneumonia within 24 hours of admission, had a
new pulmonary infiltrate on chest X-ray and had
confirmatory clinical findings. These were specified
as at least one major criterion of cough, sputum
production or fever greater than 37.8 8C or at least
two minor criteria of pleuritic chest pain, dyspnoea,
alteredmental status, consolidation on examination
or white cell count greater than 12  109/L.
Patients were excluded if they had been hospita-
lised within the previous two weeks, the pneumonia
was related to lung carcinoma or tuberculosis or if
the presentation was found on review to be due to
an alternative etiology. Severity of illness was
graded as mild, moderate or severe by the treating
physician.
Antibiotic treatment was given according to the
RDH guidelines for the treatment of adult commu-
nity-acquired pneumonia. Penicillin was used for
mild to moderate cases and ceftriaxone for severe
cases, with the exception of patients with moderate
or severe pneumonia and risk factors for melioidosis
(infection with Burkholderia pseudomallei) or Aci-
netobacter pneumonia (excess alcohol intake, dia-
betes, chronic lung disease, chronic renal failure,
steroid therapy or excess kava intake). In these
patients ceftriaxone and gentamicin were used.
The former is included because of its activity against
B. pseudomallei, the latter because of its activity
against Acinetobacter.7,8 During the monsoon ‘wet
season’, the risk of melioidosis in patients with
these risk factors increases substantially and so
ceftriaxone was replaced by ceftazidime for
patients admitted to the general ward with moder-
ate pneumonia and by meropenem for patients
admitted to the intensive care unit.9 These provide
improved coverage against B. pseudomallei. The: Royal Darwin Hospital 1986—1998.
Deaths Mortality by organism
Number of
total deaths
Percentage of
total deaths
Percentage
17 20% 17%
30 36% 50%
11 13% 38%
14 17% 54%
Community-acquired pneumonia in northern Australia 17‘wet season’ is defined as the six-month period
between December and May, inclusive. At the treat-
ing physician’s discretion coverage for ‘atypical
pneumonia’ organisms was added, usually with a
macrolide.
Microbiological investigations were standard as
performed by the treating physician. Microbiological
etiology was defined as follows: positive growth in
blood culture apart from growth of S. epidermidis or
mixed organisms; pure culture of an organism col-
lected in sputum if there were >25 leukocytes/low
power field and <10 epithelial cells/low power field
during microscopy; culture of an organism recovered
from a sterile site such as pleural fluid or pleural or
lung biopsy; culture of B. pseudomallei from any site;
greater than four-fold rise in serology titer or initial
titer of 1:160 or higher or convalescent titer of
>1:320; or positive viral polymerase chain reaction.
A data collection form was designed that included
information on demographics, risk factors, history,
examination, investigations, treatment and out-
come. Patients were prospectively enrolled in the
study and relevant information collected by one of
the investigators. Data were transferred to a compu-
terised database (Access, Microsoft) and analysed
using Stata (StataCorp, USA). Comparisons of ethni-
city and risk factorswith the regional populationwere
made using population ethnicity and risk factor data
from the Australian Bureau of Statistics.8 Statistical
significancewas determined by use of the x2 testwith
a P-value cut-off of less than or equal to 0.05. Com-
parison of continuous variables was performed using
the Student’s t-test. Overall mortality was defined as
death during admission to hospital. Attributablemor-
tality was defined as death during admission to hos-
pital due toCAPasassessedbyoneof the investigators
(JE). Approval for the study was granted by the Joint
Institutional Ethics Committee of the Royal Darwin
Hospital and the Menzies School of Health Research.Results
One hundred and sixty-seven adults admitted to the
Royal Darwin Hospital fulfilled the criteria for com-
munity-acquired pneumonia and all were included
in the analysis. Ninety-four (56.3%) were male. The
age range was 13—90 years with a median age of 45
years. Six patients were aged 13—15 years and two
aged 16 years. The residence of patients reflected
the demographics of the ‘top end’ of the Northern
Territory with 100 (59.9%) coming from urban areas,
51 (30.5%) from rural areas and 15 (9.0%) from
outside the Northern Territory.
Four (2.4%) patients were residents of nursing
homes and 14 (8.4%) were immunosuppressed. Fivewere taking long-term prednisolone, one had
chronic myeloid leukaemia and two each had HIV
infection, renal transplants, systemic lupus erythe-
matosus and previous splenectomy. Forty-six
patients (27.5%) consumed excess alcohol, 41
(24.6%) were current smokers and two (1.2%) were
current injecting drug users.
Aboriginal people were over-represented with 80
(47.9%) patients identifying as aboriginal compared
to the population from which admissions were
drawn, where approximately 20% identify as abori-
ginal (P < 0.001). Aboriginal people included in the
study were more likely to have risk factors for CAP
(Table 2). These included a documented previous
episode of CAP, bronchiectasis, chronic renal fail-
ure, diabetes and excess alcohol intake. Compared
to the aboriginal population from which admissions
are drawn,10 the rates for excess alcohol intake and
chronic renal failure were significantly higher
(P < 0.001). The rate of diabetes was no higher than
the regional aboriginal population. The rate of
bronchiectasis was not able to be compared to
the population prevalence as this is not known.
The rates of cigarette smoking, chronic obstructive
pulmonary disease, cardiac failure and pneumococ-
cal vaccination were not significantly different
between Aboriginal and non-Aboriginal patients.
A microbiological diagnosis was achieved in 38
(22.8%) cases (Table 3). In 20 (52.6%) cases this was
despite a negative blood culture. For both blood
culture positive and negative groups the most fre-
quent pathogens isolated were Streptococcus pneu-
moniae and B. pseudomallei. A small number of
other bacterial and viral pathogens were isolated.
There were no cases of the ‘atypical pneumonia’
organismsMycoplasma pneumoniae, Chlamydophila
(formerly Chlamydia) pneumoniae, legionellosis,
psittacosis or Q fever identified amongst the 16
patients who had serology specifically performed
for these. Agents active against these organisms
were used in 41 (24.6%) initial regimens and 17
(10.2%) subsequent regimens.
No high-level penicillin resistance was detected
in clinical isolates of S. pneumoniae during the study
period. Reduced sensitivity (MIC 0.1—1.0 mg/L) was
detected in 20% of isolates. The remainder were
fully sensitive to penicillin (MIC <0.1 mg/L). Season
was only a significant factor in the likelihood of
isolation of B. pseudomallei. All six cases were
identified during the ‘wet season’ (P = 0.03).
Treatment included intensive care support in 15
(9.0%) cases. Nine (5.4%) patients required intuba-
tion, four (2.4%) non-invasive respiratory support and
five (3.0%) inotropic agents. Nine (5.4%) patients
developed a para-pneumonic effusion or empyema.
Twelve (7.2%) patients suffered deterioration in renal
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Table 2 Median age, risk factors for CAP and outcome in Aboriginal and non-Aboriginal patients with community-
acquired pneumonia: Royal Darwin Hospital March 1999—February 2000.
Aboriginal patients
(N = 80) N (%)
Non-aboriginal patients
(N = 87) N (%)
P-value
Mean age (years) 47.2 49.4 0.46
Median age (years) 47.5 45.0
Pneumococcal vaccination 14 (17.5) 5 (5.7) 0.02
Previous CAP 27 (33.8) 9 (10.3) <0.001
Alcohol excess 32 (40.0) 14 (16.1) 0.001
Smoker 22 (27.5) 19 (21.8) 0.42
COPDa 26 (32.5) 26 (29.9) 0.75
Asthma 12 (15.0) 18 (20.7) 0.36
Bronchiectasis 8 (10.0) 0 (0) 0.002
Chronic renal failure 15 (18.8) 2 (2.3) <0.001
End-stage renal disease 5 (6.3) 1 (1.2) 0.08
Diabetes 21 (26.3) 9 (10.3) 0.008
Previous stroke 0 (0) 3 (3.4) 0.09
Malignancy 0 (0) 2 (2.3) 0.18
Immunosuppression 5 (6.3) 9 (10.3) 0.41
Injecting drug use 0 (0) 2 (2.3) 0.17
Liver dysfunction 12 (15.0) 6 (6.9) 0.09
Cardiac failure 19 (23.8) 12 (13.8) 0.10
Death 2 (2.5) 1 (1.1) 0.50
a COPD: chronic obstructive pulmonary disease.function, but only one (0.6%) required dialysis.
Twenty (12.0%) patients remained febrile five days
after admission and commencement of antibiotics,
but subsequently recovered fully.Table 3 Proportion of diagnostic procedures with positive
Site Proportion with positive result (%)
Blood 18/132 (13.6)
Sputum 17/98 (17.3)
Bronchial wash 2/4 (50.0)
Pleural tap 4/11 (36.4)
Pleural biopsy 1/1 (100)
Lung biopsy 1/1 (100)
Serology 3/16 (18.8)
Sputum PCRa 1/1 (100)
a PCR: polymerase chain reaction.
b Sputum culture of S. pneumoniae and H. influenzae was only ac
power field and<10 epithelial cells/low power field), the Gram stain
pneumoniae) or Gram-negative bacilli (in the case of H. influenzae
c Six patients with positive sputum cultures had positive blood c
d Positive cultures were also obtained for B. pseudomallei from
e One patient with a titer of 1:160 on admission and two patienUsing the guidelines for the treatment of com-
munity-acquired pneumonia described above, the
mortality rate attributed to pneumonia was low
with three deaths in 167 cases (1.8%). All of theseisolation and description of micro-organisms.
Organism Number positive (%)
S. pneumoniae 9 (5.4)
B. pseudomallei 5 (3.0)
P. aeruginosa 2 (1.2)
K. pneumoniae 1 (0.6)
S. aureus 1 (0.6)
S. pneumoniaeb 6 (3.6)
B. pseudomalleic 4 (2.4)
P. aeruginosac 3 (1.8)
S. aureusc 1 (0.6)
H. influenzaeb 3 (1.8)
B. pseudomalleid 1 (0.6)
RSV PCR positive 1 (0.6)
B. pseudomalleid 3 (1.8)
Mixed anaerobes 1 (0.6)
B. pseudomallei 1 (0.6)
M. tuberculosis 1 (0.6)
Influenza Ae 3 (1.8)
Varicella 1 (0.6)
cepted if the sputum was of good quality (>25 leukocytes/low
showed predominance of Gram-positive cocci (in the case of S.
) and the culture was a pure growth.
ultures: B. pseudomallei 3, P. aeruginosa 2, S. aureus 1.
other sites.
ts with titers of >1:320 on convalescent samples.
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including cardiac failure and two had dialysis-
dependent renal failure. Only one of these three
patients had amicrobiological cause identified, with
S. pneumoniae isolated from blood. Two additional
patients not included in the study were dead on
arrival at the hospital due to pneumonic melioidosis
and two patients with pneumonia on admission to
the hospital died from other causes.Discussion
Documenting the etiology and outcome of commu-
nity-acquired pneumonia is problematic due to the
difficulty in obtaining microbiological diagnoses
and defining disease in non-severe cases. This study
was limited to hospitalised patients and so does not
include a description of the mild disease able to be
treated in the community on an outpatient basis.
Nevertheless, this series is reasonably representa-
tive of people in the region hospitalised with CAP
given that most patients are admitted to RDH.
The rate of microbiological diagnosis achieved in
this study is similar to other studies using routine
clinical diagnostic techniques. Approximately half
of these diagnoses were achieved through the use of
blood cultures. Regardless of the method of isola-
tion the most important pathogens were S. pneu-
moniae and B. pseudomallei. The latter was seen
almost exclusively during the monsoon period and
was the most important pathogen during this time of
the year. In a prospective study of melioidosis it was
shown that 50% ofmelioidosis presentations are with
CAP, of which 52% are bacteremic.11 No clinical
factors other than season were predictors of CAP
due to B pseudomallei. By comparison, the epide-
miology of CAP during the ‘dry season’was similar to
most temperate areas of the world, with predomi-
nance of S. pneumoniae. The absence of any S.
pneumoniae isolates with high-level resistance to
penicillin supports the current Australian antibiotic
guidelines, which continue to recommend penicillin
for the treatment of CAP in certain circumstances.
Compared to other areas of Australia12 and else-
where in the world13—15 the impression of clinicians
working in tropical Australia has been that organisms
traditionally associated with ‘atypical’ pneumonia
are uncommon in the region. The data here are
consistent with this, with none of these organisms
identifiedduring the12months. This is also consistent
with a previous study of CAP in tropical Australia,16
although serology was not performed often enough in
either study to determine the true proportion of
pneumonias caused by these organisms. In other
years, cases of mycoplasma have been confirmed atRDH and during the study year there were several
cases in the community and at the local private
hospital. Psittacosis and legionellosis (usually Legio-
nella longbeachae) have also occasionally been diag-
nosed at RDH. In order to better define the role of
‘atypical pneumonia’ organisms in various tropical
locations including northern Australia, local studies
should be performed with prospective collections of
convalescent sera for specific serological assays.
However the very low mortality rate in this study
supports the validity of the current local guidelines,
which leave the option of adding antibiotic cover for
‘atypical pneumonia organisms,’ to the discretion of
the treating physician, while emphasising the impor-
tance of B. pseudomallei and A. baumannii cover for
defined circumstances.
In the past, melioidosis has been documented at
RDH as the most common cause of fatal adult bac-
teremic CAP.9 Early appropriate antibiotics are
important in minimising the mortality in melioidosis
and the present guidelines have been associated
with a halving of melioidosis mortality at RDH.9
Similarly, this study shows a reduction in blood
culture positive CAP mortality following revision
of the RDH CAP antibiotic guidelines in 1999 from
84/255 (32.9%) prior to revision to 1/18 (5.6%) post-
revision (P = 0.015). It is suggested that similar
processes of identification of local CAP epidemiol-
ogy, development of practice guidelines and audit of
the use of such guidelines are important steps in
improving the care of people with CAP in settings
where guidelines from societies in industrialised
countries or from international organisations such
as theWHO are likely to be of limited relevance. The
RDH CAP guidelines are now incorporated into Aus-
tralian CAP guidelines as recommendations for the
treatment of CAP acquired in tropical Australia.17
The demographic characteristics of this series are
more similar to those of developing countries than
series from Europe or USA. This study describes a
relatively young median age, a low rate of immuno-
suppressive conditions or injecting drug use and a
relatively high proportion of people from rural areas
andof indigenousbackground.However, an important
difference from many developing countries is the
continuing low rate of HIV in the population. The high
rateof chronicmedical conditions is also similar to the
rapidly urbanising populations of many ‘middle-
income’ countries. In this setting, in a tropical region,
a low mortality rate has been achieved for hospita-
lised patients with CAP using a locally developed,
season-specific antibiotic protocol and intensive care
support when necessary. The low mortality rate and
incomplete data on arterial blood gas concentrations
preclude the comparison of these data with those
used to develop CAP grading scales such as the Pneu-
20 J.H. Elliott et al.monia Severity Index (PSI).18 In contrast with the
extensive work on grading of CAP in children in devel-
oping countries,19 there are relatively few data to
inform risk stratification in adults with CAP in
resource-limited and/or tropical settings. In the
absence of more appropriate scales at the time of
this study, severity of disease was graded by treating
physicians as mild, moderate or severe. The PSI has
recently been adapted for use in tropical Australia
using the data presented here and from earlier stu-
dies20 and is included in the current national guide-
lines for the management of CAP in tropical areas.17
This study documents the increased burden of
severe lower respiratory tract infections in theAbori-
ginal people of tropical Australia. They were over-
represented in the overall number of admissions,
were younger and were more likely to have had
previous episodes of CAP. These findings also indicate
the importance of chronic conditions in Aboriginal
adults predisposing to CAP, particularly chronic lung
disease, chronic renal failure and excess alcohol
intake. In addition to traditional approaches made
to reduce the burden of acute respiratory infections,
such as improvement in environmental conditions
and pneumococcal and influenza vaccination,
attempts to reduce the burden of lung disease in
Aboriginal people should include interventions tar-
geting preventable chronic disease, including cigar-
ette smoking, diabetes, chronic renal failure and
excess alcohol consumption.
In summary, treatment guidelines for CAP based
upon local epidemiology have been developed for
tropical northern Australia, where melioidosis has
been an important cause of mortality. This study
illustrates how mortality can be minimised using a
process of determining local CAP etiology, develop-
ing treatment guidelines and auditing patient man-
agement and outcomes.
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